InflaRx (IFRX) Stock Chart & Stock Price History $0.80 -0.01 (-1.83%) Closing price 04:00 PM EasternExtended Trading$0.85 +0.05 (+6.60%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock InflaRx Stock Price Performance The InflaRx (IFRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 40.28%, with a year-to-date return of -67.60%. In the past month, the stock has decreased 8.64%, reflecting recent market activity. As of the latest close, InflaRx traded at $0.82 with a market cap of $55.05 million and volume of 667,374 shares. Five years ago, the stock traded at $4.97, representing a 83.90% decrease over that period. At the time, it had a market cap of $129.18 million and a volume of 356,578 shares. Receive IFRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.95%1 Month Performance-8.64%3 Month Performance-49.99%Year-To-Date Performance-67.60%1 Year Performance-40.28%5 Year Performance-83.90% IFRX Stock Chart for Friday, August, 8, 2025 IFRX Chart by TradingView InflaRx Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$0.82$0.80-2.41%$0.86$0.78158,942 shs$53.72 million08/07/2025$0.84$0.82-2.38%$0.84$0.74667,374 shs$55.05 million08/06/2025$0.88$0.84-4.55%$0.90$0.84159,901 shs$56.39 million08/05/2025$0.89$0.88-0.95%$0.92$0.86185,027 shs$59.07 million08/04/2025$0.86$0.89+3.30%$0.92$0.8596,094 shs$59.64 million08/01/2025$0.91$0.86-4.97%$0.91$0.84123,610 shs$57.73 million07/31/2025$0.88$0.91+2.84%$0.95$0.87284,307 shs$60.75 million07/30/2025$0.87$0.88+0.69%$0.95$0.85379,524 shs$59.07 million07/29/2025$0.88$0.87-0.33%$0.89$0.84103,981 shs$58.67 million07/28/2025$0.90$0.88-2.43%$0.90$0.86198,110 shs$58.87 million Get the Latest News and Ratings for IFRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$0.85$0.90+5.72%$0.90$0.85168,918 shs$60.33 million07/24/2025$0.86$0.85-1.01%$0.89$0.83254,355 shs$57.07 million07/23/2025$0.84$0.86+1.67%$0.87$0.83168,908 shs$57.65 million07/22/2025$0.86$0.84-1.44%$0.86$0.8291,418 shs$56.71 million07/21/2025$0.86$0.86-0.81%$0.89$0.82134,027 shs$57.53 million07/18/2025$0.87$0.86-0.45%$0.88$0.83177,355 shs$58 million07/17/2025$0.85$0.87+2.11%$0.87$0.82239,556 shs$58.26 million07/16/2025$0.81$0.85+4.42%$0.89$0.8372,183 shs$57.06 million07/15/2025$0.89$0.81-8.74%$0.89$0.80406,628 shs$54.64 million07/14/2025$0.88$0.89+1.35%$0.91$0.85167,662 shs$59.88 million07/11/2025$0.90$0.88-2.21%$0.93$0.872.67 million shs$59.08 million07/10/2025$0.89$0.90+0.66%$0.92$0.88168,264 shs$60.42 million07/09/2025$0.88$0.89+2.08%$0.90$0.86215,162 shs$60.02 million07/08/2025$0.82$0.88+6.82%$0.89$0.82441,261 shs$58.80 million07/07/2025$0.81$0.82+1.86%$1.00$0.801.02 million shs$55.05 million Related Companies Adherex Technologies Stock Chart Design Therapeutics Stock Chart Larimar Therapeutics Stock Chart Galectin Therapeutics Stock Chart ProQR Therapeutics Stock Chart Alumis Stock Chart AC Immune Stock Chart Y-mAbs Therapeutics Stock Chart Canopy Growth Stock Chart SOPHiA GENETICS Stock Chart Receive IFRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IFRX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InflaRx N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share InflaRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
